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Abstract
Reference and type strains of well-known bacteria have been a cornerstone of microbiology research for decades. The 
sharing of well-characterized isolates among laboratories has run in parallel with research efforts and enhanced the 
reproducibility of experiments, leading to a wealth of knowledge about trait variation in different species and the underlying 
genetics. Campylobacter jejuni strain NCTC 11168, deposited at the National Collection of Type Cultures in 1977, has been 
adopted widely as a reference strain by researchers worldwide and was the first Campylobacter for which the complete 
genome was published (in 2000). In this study, we collected 23 C. jejuni NCTC 11168 reference isolates from laboratories 
across the UK and compared variation in simple laboratory phenotypes with genetic variation in sequenced genomes. 
Putatively identical isolates, identified previously to have aberrant phenotypes, varied by up to 281 SNPs (in 15 genes) 
compared to the most recent reference strain. Isolates also display considerable phenotype variation in motility, morphol-
ogy, growth at 37 °C, invasion of chicken and human cell lines, and susceptibility to ampicillin. This study provides evidence 
of ongoing evolutionary change among C. jejuni isolates as they are cultured in different laboratories and highlights the 
need for careful consideration of genetic variation within laboratory reference strains. This article contains data hosted by 
Microreact.
DATA SUMMARy
Short read data are archived on the NCBI SRA associated with 
BioProject accession PRJNA517467 (https://www. ncbi. nlm. 
nih. gov/ bioproject/ PRJNA517467).
Long read data are archived on the ENA associated with 
BioProject accession PRJEB33069 (https://www. ebi. ac. uk/ 
ena/ data/ search? query= PRJEB33069).
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All assembled genomes are also available on figshare (doi: 
10.6084/m9.figshare.7849268). Phylogeny is visualized on 
microreact: https:// microreact. org/ project/ NCTC11168.
INTRODUCTION
The sharing of bacterial reference or type strains among labo-
ratories is a fundamental part of microbiology. This informal 
and often uncelebrated enterprise has supported academic, 
health, food and veterinary research worldwide, underpin-
ning microbiology innovation. The history of the exchange 
and classification of bacterial type strains has incorporated 
the work of some of the most influential microbiologists 
[1]. One such strain belongs to the important food-borne 
pathogen species Campylobacter jejuni.
For C. jejuni, the publication of a simplified culturing tech-
nique and deposition of a reference isolate at the National 
Collection of Type Cultures (NCTC 11168) in 1977 (by 
Martin Skirrow) marked the end of the first century of 
research into this organism [2]. The first description of an 
organism likely to be Campylobacter was made in Naples in 
1884. Theodor Escherich observed spiral bacteria in stool 
specimens from patients with diarrhoeal disease but he 
was unable to culture them [3, 4]. Successful isolation of 
Bacterium coli commune (now Escherichia coli) from his 
young dysenteric patients helped pioneer bacterial genetics 
and lay the foundations of modern microbiology [1, 5]. 
However, throughout his career, Escherich continued to 
identify ‘spirilla’ in cases of cholera-like and dysenteric 
disease. It is likely that the microorganisms he described 
were Campylobacter with their typical spiral morphology 
and association with enteritis [4, 6].
Early in the 20th century researchers investigating veteri-
nary cases of fetal abortion and winter dysentery in cattle 
[7] described several species that would later become part of 
the genus Campylobacter, including Vibrio jejuni [8], V. fetus 
[9], V. fetus venerealis and V. fetus intestinalis [10]. Isola-
tion techniques that permitted the growth of Campylobacter 
from human faeces drew attention to its importance as a 
human pathogen [11–13]. The genus name Campylobacter 
(meaning curved rod) was proposed by Sebald and Véron 
in 1963 and subsequently verified in 1973 with the broader 
acceptance of Campylobacter species as human pathogens 
[14, 15]. Skirrow’s more convenient culturing technique 
and the availability of a model reference strain sparked 
renewed interest in Campylobacter research later in the 20th 
century [16, 17]. Model strains allowed for comparison of 
experiments within laboratories and isolates were passed 
among laboratories across the world [18–23]. When the C. 
jejuni NCTC 11168 genome was sequenced in 2000 [24] 
this type strain was cemented as an important reference 
strain for Campylobacter research. Additional detail was 
added to the C. jejuni genome following its re-annotation 
(accession: AL11168.1), including revised coding sequence 
(CDS) identification incorporating potential for phase vari-
ation [25–29].
Today, many aspects of the biology of this organism are well 
characterized. Identification of genomic regions primed for 
post-translational modification, in particular decoration of 
surface proteins with glycans [30], pseudaminic acid [31–33] 
and legionaminic acid [34], have improved understanding 
of the mechanisms of ganglioside mimicry [35], epithelial 
cell invasion, host immune-evasion, colonization [36, 37] 
and development of neurological sequelae such as Guillain-
Barré syndrome [38]. Furthermore, insights into virulence 
traits including strategies to sequester the iron required for 
infection were detailed using NCTC 11168 [39–41]. Vaccine 
targets have been identified [42–44] and the mechanisms of 
core metabolic processes [45, 46], biofilm production [47–51], 
capsule production [52] and resistance to oxidative stress have 
been elucidated [53, 54]. Accidental passage through a labora-
tory worker also identified putative human host adaptations 
in vivo [55].
Since 1977 the NCTC 11168 strain has been an important 
part of efforts to better understand this pervasive pathogen. 
However, there are limitations to the use of type strains, 
the most obvious being that bacteria display considerable 
variation within species. For example, in C. jejuni, some 
strains cause a significant amount of disease in humans 
while others do not – owing, in part, to their inability to 
survive the passage from reservoir host through the food 
production chain to contaminate human food [56]. This 
kind of phenotypic variation among strains is well docu-
mented in many species and is a central reason for the 
growing emphasis on population genomics when trying to 
understand the ecology and evolution of bacteria [57]. A 
second, more inconspicuous limitation on the use of type 
strains shared among laboratories is that they might not all 
be the same. Strains are not sensu stricto clones and may 
display low levels of genetic variation. Clearly, when frozen 
there is little opportunity for genome evolution to occur 
[58]. However, whenever there is growth, for example in the 
process of subculturing isolates, there is an opportunity for 
genetic variability to be generated within the population. 
This may be important for interpreting research findings in 
different groups as even single SNPs can potentially have an 
impact on phenotype, for example in antimicrobial resist-
ance [59] or host tropism [60]. The aim of the present study 
was to investigate if, over time, multiple passages under 
Impact Statement
In this paper, we comment on the changing role of labora-
tory reference strains. While the model organism allows 
basic comparison within and among laboratories, it is 
important to remember the effect even small differences 
in isolate genomes can have on the validity and repro-
ducibility of experimental work. We quantify differences 
in 23 reference Campylobacter genomes and compare 
them with observable differences in common laboratory 
phenotypes.
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Fig. 1. The location of laboratories contributing C. jejuni NCTC 11168 isolates. The most recent NCTC 11168 isolate was obtained by 
Swansea (isolate 13) in 2016 from the NCTC collection. Other isolates obtained directly from the NCTC collection are coloured black, 
while isolates obtained via a second laboratory are coloured white.
potentially different growth conditions in different labora-
tories have introduced genotypic and phenotypic variation 
into a collection of NCTC 11168 C. jejuni.
MeTHODS
Isolates and genome sequencing
Twenty-three laboratory reference C. jejuni NCTC 11168 
isolates from around the UK were collected and (re)sequenced. 
The year in which the laboratory received the isolate is noted 
along with its known heritage (Table 1). DNA was extracted 
using the QIAamp DNA Mini Kit (Qiagen), according to the 
manufacturer’s instructions and quantified using a Nanodrop 
spectrophotometer. Genome sequencing was performed on 
an Illumina MiSeq sequencer using the Nextera XT Library 
Preparation Kit. Libraries were sequenced using a 2× 300 
bp paired end v3 reagent kit (Illumina). Short read paired-
end data were trimmed using trimmomatic (version 0.35; 
paired-end mode) and assembled using the de novo assembly 
software, SPAdes (version 3.8.0; using the careful command). 
The average number of contigs in the resulting assemblies 
was 19.7 (range: 13–36) for an average total assembled 
sequence size of 1 629 408 bp (range: 1 612 402–1 694 909 
bp). The average N50 contig length was 173 674 bp (range: 
100 444–271 714 bp) (Table S1, available in the online version 
of this article).
Population structure and phylogenies
Sequence alignments and genome content comparison analyses 
using blast were performed gene-by-gene, as implemented in 
the BIGSdb platform [61, 62] as described in previous Campy-
lobacter studies [63–66]. A gene was considered present in a 
given genome when its sequence aligned to an NCTC 11168 
locus with more than 70 % sequence identity over at least 50 
% of sequence length using blast (File S1, available in the 
5Pascoe et al., Microbial Genomics 2019;5
online version of this article) [67]. Genomes were aligned by 
concatenating single-gene alignments using mafft [68]. For 
context, collected NCTC 11168 isolates were augmented with 
83 previously published genomes representing the known 
genetic diversity in C. jejuni (Table S2). Genes present in 
90 % or more of the isolate genomes were aligned (1 359 883 
bp; File S2) and a maximum-likelihood phylogeny was recon-
structed in FastTree (version 2.1.10; with the generalized time 
reversible substitution model) [69]. A second alignment of 
just the collected NCTC 11168 strains was made (1 555 326 
bp; File S3) to build an additional maximum-likelihood tree, 
which was used as input for ClonalFrame-ML to mask puta-
tive recombination sites (version 1.11–3) [70] and visualized 
in microreact: https:// microreact. org/ project/ NCTC11168 
[71].
estimating genome variation
Sequence reads were compared to the completed NCTC 11168 
reference genome (AL11168.1) using snippy (version 3.2dev; 
File S4) [72] to estimate nucleotide differences between our 
laboratory reference isolates and the originally sequenced 
genome. Assembled genomes were annotated with prokka 
(version 1.13) [73] and the number of polymorphisms intro-
duced by mutation and recombination was inferred using 
Gubbins (version 2.3.1) [71] for each isolate (per branch; File 
S5). All high-performance computation was performed on 
mrc climb in a conda environment [74, 75].
Phenotype testing
Isolates were recovered from frozen storage on Columbia 
blood agar (E and O Labs) and incubated under microaerobic 
conditions at 37 °C and subcultured in Mueller-Hinton broth 
(Oxoid) and grown microaerobically overnight at 37 °C.
Bacterial growth assays
Broth cultures were standardized to an OD600 of 0.05. For 
growth curves at 37 and 42 °C, 20 µl of the standardized broth 
culture was added to 180 µl of Mueller-Hinton broth in a 
microtitre plate. Optical densities were measured at hourly 
intervals over a period of 48 h using an OMEGA FLUOstar 
(BMG LabTech) plate reader with an atmospheric environ-
ment of 10 % CO2 and 3 % O2. Growth curve assays were 
performed in triplicate, with three technical replicates for each 
biological replicate. Multiple comparisons among isolates at 
37 and 42 °C were compared using a one-way ANOVA with 
a Tukey post-test [76].
Swarming assays and motility
For each isolate, a 1 ml aliquot of the standardized preculture 
(OD600 0.05) was transferred to 5 ml of fresh Mueller-Hinton 
broth and 2 µl was pipetted onto the centre of semi-solid 
Mueller-Hinton agar [11.5 g Muller Hinton broth, 2.5 g 
Agar 3 (Oxoid) in 500 ml deionized water] and incubated at 
42 °C for 24 h. Variation in isolate swarming was observed 
on Mueller-Hinton motility plates. Motile isolates spread 
across the plates and halo diameters were measured after 1 
day of incubation. Isolates were grouped into three categories: 
non-motile isolates did not spread across the plate; isolates 
with halo diameters up to 1.5 cm were categorized as motile; 
and those with halos of a diameter above 1.5 cm were desig-
nated as hyper-motile [36].
Invasion assays
A chicken gut epithelial cell line (MM-CHiC clone, 8E11; 
Micromol) and a human colon epithelial adenocarcinoma 
cell line (HT-29) were used to assay invasion of Campylo-
bacter in vivo. A 24-well plate was seeded with 8E11 cells 
in assay medium [modified McCoy’s 5A/DMEM/F-12 with 
l-glutamine (5 mM) and supplemented with 5 % FBS] and 
incubated at 37 °C in 5 % CO2 for between 4 and 7 days. Liquid 
cultures were standardized by diluting with Mueller-Hinton 
broth to between 0.030 and 0.080. Aliquots of 200 µl from each 
isolate were deposited into a 96-well plate and diluted serially. 
The original stock and dilutions were spread onto Columbia 
horse blood agar and incubated for 24 h microaerobically at 
42 °C. Once the cells had reached confluent growth, the 
medium was removed and the monolayer was washed three 
times with warm PBS. An aliquot of 1 ml pre-warmed anti-
biotic-free supplemented Dulbecco's modified Eagle medium 
(DMEM) was added to each well and inoculated with 100 µl 
1×107 c.f.u. Following incubation in 5 % CO2 at 37 °C for 4 h, 
the cells were washed twice with 2 ml PBS supplemented with 
4 µl (100 µl ml−1) gentamicin and incubated for a further 1.5 
h. Cells were washed three times with PBS and an aliquot of 
1 ml of warmed TrypLE (Gibco) was added to each well and 
incubated at 37 °C for 10 min. The lysed monolayer solution 
was diluted serially and spread onto Columbia horse blood 
agar in duplicate. Plates were incubated overnight at 42 °C in 
a microaerobic environment and enumerated pre- and post-
invasion to calculate the percentage of invaded inoculum. 
Assays with human HT-29 cells were performed with McCoys 
growth media. Invasion assays were performed in triplicate 
and analysed using unpaired t-tests with Welch’s correction.
ReSUlTS AND DISCUSSION
Not all reference strains are equal
Since its deposition at the NCTC there have been two main 
dissemination hubs of NCTC 11168. Ten of the 23 isolates we 
collected were obtained by contributing laboratories directly 
from the NCTC collection, while 13 isolates had come via 
another laboratory (Fig. 1). DNA was extracted from each 
isolate and sequenced, and the genome was assembled (Table 
S1). All 23 isolates clustered closely in the host-generalist 
ST-21 lineage when compared on a maximum-likelihood 
phylogenetic tree (Fig. 2a). This suggests that despite some 
phenotypic heterogeneity, all isolates derived were from 
a recent common ancestor and no strains were misidenti-
fied during passage. Micro-evolutionary differences among 
closely related NCTC 11168 isolates were observed on a 
recombination-free phylogeny constructed using ClonalF-
rameML (Fig. 2b). Genomes were compared to the original 
NCTC 11168 genome and as many as 281 SNP differences 
were observed (up to 15 genes in isolate 17) among collected 
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Fig. 2. Genetic variation among C. jejuni NCTC 11168 genomes. (a) NCTC 11168 isolates were contextualized with 83 previously published 
genomes representing the known genetic diversity in C. jejuni (total of 106 isolates). Genes present in 90 % or more of the isolate genomes 
were aligned (1 359 883 bp) and a maximum-likelihood phylogeny was reconstructed in FastTree2 with the generalized time reversible 
substitution model. Bar, genetic distance of 0.01. (b) Recombination was masked using ClonalFrame-ML to produce an alignment of the 
NCTC 11168 isolates only (n=23; 1 555 326 bp). Bar, 15 nt substitutions. (c) The position of all nucleotide substitutions identified using 
snippy were mapped against the original NCTC 11168 genome (AL11168.1). SNPs found within coding regions (CDS) are represented 
with circles and SNPs located in intergenic regions are represented with an X. Gene names are given where variation was observed in 
10 or more of the isolates.
laboratory strains and the reference (Fig.  2c; Table  1). 
However, in 21 of 23 isolates (91%) there were 32 or fewer SNP 
differences compared to the reference (Table 1). There was an 
average of 29 SNP differences between the laboratory strains 
and the reference, and the fewest SNPs in any comparison was 
eight SNP differences (in five genes in isolate 1).
Under ideal storage conditions one might not expect to 
see any evidence of recent recombination in the laboratory 
reference strains. Nevertheless, we estimated the number 
of mutations and recombination events using Gubbins. In 
total, 436 of the 632 SNPs (69%) we identified were found 
within protein coding regions, of which 83 were synonymous 
mutations (19 %; File S5). The only isolate where we inferred 
any recombination was isolate 17, which has acquired four 
recombination blocks comprising a total of 14 816 bp, incor-
porating 283 SNPs. In comparison, 29 SNPs were identified 
outside these recombination blocks (as a result of mutation), 
corresponding to a ratio at which recombination introduces 
nucleotide changes, relative to mutation (r/m) of 9.76 (File 
S5). This isolate also lost a block of 15 genes (Cj1319-1333; 
File S1), which includes a maf-family gene (maf3/Cj1334) 
involved in post-translational modification of flagellins. Also 
missing were the neuC2/Cj1328, neuB2/Cj1327, ptmA/Cj1332 
and ptmB/Cj1331 genes involved in the addition of pseua-
minic/legionaminic acid to C. jejuni flagellins [32, 77, 78]. 
A knockout mutant of the final gene in this block, Cj1333, 
demonstrated compromised agglutination and reduced 
invasion (in INT-407 cells) [78]. This region of the C. jejuni 
genome is prone to recombination and has shown a high 
level of diversity and is often implicated in bacterial viru-
lence [34, 35, 37, 79–82]. Isolate 17 was hyper-motile and also 
among the most invasive isolates when tested against chicken 
cell lines, but invaded human cell lines poorly (Table 2).
Isolate motility was tested in vitro [83] and phenotypic vari-
ation was observed among NCTC 11168 isolates (Table 2). 
Since its original dissemination, motile, non-motile and 
hyper-motile variants have been reported [25, 28, 84]. Despite 
previous observations describing increased motility, only 
three strains were categorized as hyper-motile in our assays 
(swarming >1.5 cm), all of which had been passed between 
at least two laboratories before entering our collection. Only 
50 % of the isolates received by laboratories directly from 
the NCTC collection were motile (Table  2). Changes in 
motility can be a result of differences in the flaA and flaB 
genes resulting in attenuated flagella assembly [36]. However, 
we did not identify any non-synonymous mutations within 
the flaA or flaB genes. A shared frameshift mutation was 
identified in two hyper-motile isolates (11 and 16) within 
the core motor protein, fliR [85–87]. Isolate motility is also 
influenced by phase-variable gene expression as a result of 
upstream homopolymeric repeat regions [24, 88, 89]. Three 
motility-associated genes (maf1/Cj1348, maf4/Cj1335 and 
7Pascoe et al., Microbial Genomics 2019;5
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Fig. 3. Phenotypc variation among C. jejuni NCTC11168 genomes. Invasion assays were carried out for strains categorized by motility 
phenotypes in (a) human HT-29 and (b) chicken cell lines. For each isolate the percentage of invaded original inocula is plotted with a 
mean line and bars representing sem. Comparisons were made between (c) invasiveness in these cell lines and (d) maximum growth 
at different temperatures, with hyper-motile isolates coloured red. The minimum inhibitory concentration (MIC) of ampicillin was 
determined for isolates grouped by motility (e).
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maf7/Cj1342c) were among 31 phase-variable regions recently 
identified in NCTC 11168 [90] and were among SNPs we 
identified in non-coding intergenic regions (196 of 632; 31 %; 
File S4). Twelve genes (Cj0045c, Cj0184, mreB, cheA, Cj0431, 
Cj0455c, Cj0564, Cj0807, Cj1145c, Cj1306c, gapA and Cj1468) 
contained nucleotide polymorphisms in 10 or more NCTC 
11168 isolates, of which five have been shown to be subject to 
phase variation (Cj0045c, Cj0455c, Cj0564, gapA and Cj1468; 
Fig.  2c) [89]. Growth of motile bacteria in culture media 
can result in loss of motility as flagella construction is ener-
getically expensive [91, 92]. In batch culture, rapid growth is 
prioritized and loss of flagella can be advantageous [93, 94].
Adequate flagella construction is an important virulence 
factor because, in addition to motility, flagella also contribute 
to invasion and secretion [95, 96], without which coloniza-
tion is impaired [28]. The ability of isolates to invade human 
and chicken intestinal epithelial cell lines was tested in vitro 
by a gentamicin protection assay (Fig. 3a, b). Fourteen of 
21 isolates tested invaded the 8E11 chicken cell line more 
effectively compared to the human HT-29 cell line (Fig. 3c). 
On average, motile (n=13, 2 and 3 % of the original inoculum 
invaded chicken and human cell lines, respectively) and 
hyper-motile isolates (n=3; 2 % of the original inoculum 
invaded chicken and human cell lines) invaded both cell 
lines in greater numbers than non-motile isolates (n=5; 
1 and 2 % of the original inoculum invaded chicken and 
human cell lines, respectively; Table 2; Fig. 3a, b). Several 
genes containing SNPs in multiple isolates have been shown 
previously to contribute to increased invasion and virulence, 
including mreB (n=14), cheA (n=14), Cj0431 (n=22), Cj0455 
(n=20), Cj0807 (n=22) and Cj1145 (n=10) [55, 81, 97]. Isolate 
growth was tested at 37 and 42 °C, with all growing to a higher 
optical density at avian body temperature (42 °C) (Fig. 3d). 
Isolate 15 grew particularly poorly at 37 °C. We identified the 
OXA-61 gene in the majority of isolates, but only two were 
resistant to ampicillin, according to CLSI guidelines (isolates 
3 and 8; Table 2; Fig. 3e) [98]. No SNP changes were observed 
in cmeABC genes in any isolate (File S1).
The role of model strains in an age of population 
genomics
In most cases (21 of 23 isolates; 91%) we observed fewer 
than 32 SNPs between the laboratory isolate and the type 
strain deposited in the NCTC archive. However, even these 
minor changes are associated with observable phenotypic 
differences (motility and invasion as seen here). This could 
be seen as a challenge to the reproducibility of experiments 
in different laboratories that use ostensibly identical strains 
[55, 97]. It is accepted among microbiologists that there is 
potential for variation among type strains that may display 
considerable genome plasticity, such as in Helicobacter pylori 
[99]. Consistent with this, variants of C. jejuni NCTC 11168 
are defined as motile/non-motile, colonizer/non-colonizer for 
use in specific experiments.
Technical advances in high-throughput genome sequencing 
and analysis methods continue to improve understanding 
of C. jejuni from bottom-up studies that test the function 
of specific genes or operons, often with insertion or dele-
tion mutants [55, 97], to top-down comparative genomic 
approaches in which isolates are clustered by phenotype and 
associated genomic variations are identified in large genome 
collections [50, 64, 100]. Early genome typing using DNA 
microarrays hinted at the level of diversity among C. jejuni 
isolates [27, 101], and comparisons of large isolate genome 
collections are now linking strain variation to differences 
in ecology [65, 102–105], epidemiology and evolution 
[63, 100, 106–110]. Advances in sequencing technology are 
helping us to study genome variation in greater depth, and 
long read sequencing of isolate 2 identified large inversions 
(>90 000 bp) compared to the original finished genome (Table 
S1).
In conclusion, the genotypic and phenotypic differences 
among NCTC 11168 strains in this study, probably as a 
result of evolution during repeated passages, emphasizes 
the need for laboratories to maintain isolate collections with 
detailed records and good culture practices. This essentially 
reaffirms the work of microbiology pioneers who developed 
practices to minimize variation between strains and labora-
tories. However, in the genomics era, it may also be prudent 
to sequence strains more routinely, particularly as the costs 
continue to decline. While the interpretation of experiments 
using reference type strains may be adapting to more detailed 
genomic data and improved understanding of genome evolu-
tion, the strains themselves remain an essential resource in 
microbiology. The perceived power of large-scale compara-
tive genomics and statistical genetics studies typically lies in 
the ability to identify genes or genetic variation that confers 
putative functional differences to the bacterium. Confirming 
these associated gene functions [56] requires traditional 
microbiology based upon a detailed understanding of reliable 
reference type control strains such as NCTC 11168.
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